Comparative immune response of Typbar TCV® (typhoid conjugate vaccine) in extremes of age: An Indian experience

Typhoid fever is a significant health concern in low- and middle-income countries, with millions of cases and thousands of deaths each year. Typhoid Conjugate Vaccines, such as Typbar TCV®, have been developed to provide longer-lasting protection for young children. This publication includes the rea...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Human Vaccines & Immunotherapeutics
المؤلفون الرئيسيون: Krishna Mohan Vadrevu, Siddharth Reddy Chiteti, Raju Dugyala, Vinay Kumar Aileni, Akhila. Kunta, Badri Narayan Patnaik, Raches Ella
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Taylor & Francis Group 2025-12-01
الموضوعات:
Typbar TCV®
typhoid conjugate vaccine
typhoid
Typhim Vi
salmonella Typhi
Immunogenicity
الوصول للمادة أونلاين:https://www.tandfonline.com/doi/10.1080/21645515.2025.2507912

الانترنت

https://www.tandfonline.com/doi/10.1080/21645515.2025.2507912

مواد مشابهة